Warner-Lambert Company, Pfizer, Inc., Bayer Corporation, Del Pharmaceuticals, Inc., Del Laboratories, Inc. and Care Technologies, Inc. v. Katherine Mills and Veronica Evans, Individually and on Behalf of All Others Similarly Situated

CourtCourt of Appeals of Texas
DecidedAugust 31, 2005
Docket09-02-00173-CV
StatusPublished

This text of Warner-Lambert Company, Pfizer, Inc., Bayer Corporation, Del Pharmaceuticals, Inc., Del Laboratories, Inc. and Care Technologies, Inc. v. Katherine Mills and Veronica Evans, Individually and on Behalf of All Others Similarly Situated (Warner-Lambert Company, Pfizer, Inc., Bayer Corporation, Del Pharmaceuticals, Inc., Del Laboratories, Inc. and Care Technologies, Inc. v. Katherine Mills and Veronica Evans, Individually and on Behalf of All Others Similarly Situated) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Warner-Lambert Company, Pfizer, Inc., Bayer Corporation, Del Pharmaceuticals, Inc., Del Laboratories, Inc. and Care Technologies, Inc. v. Katherine Mills and Veronica Evans, Individually and on Behalf of All Others Similarly Situated, (Tex. Ct. App. 2005).

Opinion

In The

Court of Appeals



Ninth District of Texas at Beaumont

____________________



NO. 09-02-173 CV



WARNER-LAMBERT COMPANY, PFIZER, INC., BAYER CORPORATION,

DEL PHARMACEUTICAL, INC., DEL LABORATORIES, INC., AND

CARE TECHNOLOGIES, INC., Appellants



V.



KATHERINE MILLS AND VERONICA EVANS, INDIVIDUALLY

AND ON BEHALF OF OTHERS SIMILARLY SITUATED, Appellees



On Appeal from the 163rd Judicial District Court

Orange County, Texas

Trial Cause No. B-10023-C



MEMORANDUM OPINION

Katherine Mills and Veronica Evans sued appellants Warner-Lambert Company, Bayer Corporation, Pfizer, Inc., Del Pharmaceutical, Inc., Del Laboratories, and Care Technologies, Inc., alleging breach of implied warranty and violations of the Texas Deceptive Trade Practices Act (DTPA). See Tex. Bus. & Com. Code Ann. §§ 2.314, 17.50(a)(2) (Vernon 1994, 2002). The trial court entered an order granting appellees' motion for class certification under then Rule 42(b)(4) of the Texas Rules of Civil Procedure. (1) Appellants filed an interlocutory appeal pursuant to Tex. Civ. Prac & Rem. Code Ann. § 51.014(a)(3) (Vernon Supp. 2005). In a prior opinion, we held the trial court lacked subject matter jurisdiction because appellees' claims were preempted by federal law. See Warner-Lambert Co. v. Mills, 117 S.W.3d 488 (Tex. App.--Beaumont 2003), rev'd, 157 S.W.3d 424 (Tex. 2005). The Supreme Court reversed our judgment and remanded the case to this Court for consideration of the other issues raised on appeal. See Mills v. Warner-Lambert Co., 157 S.W.3d 424 (Tex. 2005).

In their first issue, appellants assert the class certification order should be reversed because the trial court failed to perform the rigorous analysis required for class certification. See Southwestern Ref. Co., Inc. v. Bernal, 22 S.W.3d 425, 435 (Tex. 2000). A certification order must explain how the claims will be tried "to allow reviewing courts to assure that all requirements for certification under Rule 42 have been satisfied." State Farm Mut. Auto. Ins. Co. v. Lopez, 156 S.W.3d 550, 556 (Tex. 2004). While the order here purports to address a common question of fact, it recognizes the possibility of individual issues, and it does not adequately explain how the claims will be tried in a way that will permit the assertion of defenses and provide due process. The order does not adequately analyze how the claims will be properly determined under the proposed trial plan. We reverse the certification order and remand for proceedings consistent with this opinion.

The class representatives are consumers who purchased appellants' products for "personal consumption or for their family members to cure lice infestation." They claim the products failed to cure the infestations because the "products contain a lice-resistant pesticide." Appellees also contend that appellants falsely claim their products cure lice infestation and kill lice eggs. In their brief in this Court, appellees describe their claims as follows:

So, let us be clear about the nature of the claims. The plaintiffs are contending that the defendants' products amount to snake oil. The products are inherently useless and worthless. They do not kill lice. They do not cure lice infestations. The defendants' position that the products "work" is based on pure illusion.



Appellees explain as follows:



[T]here is scientific proof and proof from the Defendants' own files that the products do not cure head lice infestations. The mere fact that some consumers may perceive the products to have "worked" does not mean that the products actually did work or that they "performed satisfactorily. . . ."



According to appellees, "the evidence shows that what gets rid of a lice infestation is careful and prolonged combing." Appellees seek "to recover purely economic loss based on breach of implied warranty" rather than any damages for personal injuries. They state, "This is not a suit in which the Plaintiffs are contending that the products were ineffective merely in particular cases or for particular people." Rather, appellees contend the products are not chemically formulated to work for anyone. Appellees rely on this alleged uniform defect as the foundation for the class certification.

The trial court certified a class defined as follows:

All Texas consumers of Warner-Lambert Company's "NIX Lice Treatment," Bayer Corporation's and Pfizer, Inc.'s "RID Lice Killing Shampoo," Del Pharmaceutical, Inc.'s and Del Laboratories, Inc.'s "Pronto Lice Treatment," and Care Technologies, Inc.'s "Clear Lice Egg Remover" or "Clear Lice Killing Shampoo," who, for purposes of breach of warranty action, purchased said products in Texas from January 17, 1997 to present (four years from the date of filing this class action) and those consumers who purchased, for purposes of the DTPA bre[a]ch of warranty action, from January 17, 1999 to present (two years from the date of filing this action), and who have not received a full refund for the purchase of such products. (2)



Appellants do not challenge the class definition. They challenge the assertion that their products never work, and they contend the trial court has not adequately analyzed the propriety of class certification.

A trial court must perform a rigorous analysis to determine whether all prerequisites to certification have been met. Bernal, 22 S.W.3d at 435. It is improper for a court to certify a class without knowing, and indicating in the certification order, how the claims can and will likely be tried. Id. To adequately analyze the propriety of class certification, "[g]oing beyond the pleadings is necessary, as a court must understand the claims, defenses, relevant facts, and applicable substantive law in order to make a meaningful determination of the certification issues." Id. (quoting Castano v. American Tobacco Co., 84 F.3d 734, 744 (5th Cir. 1996)).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dianne Castano v. The American Tobacco Company
84 F.3d 734 (Fifth Circuit, 1996)
Snyder Communications, L.P. v. Magana
142 S.W.3d 295 (Texas Supreme Court, 2004)
State Farm Mutual Automobile Insurance Co. v. Lopez
156 S.W.3d 550 (Texas Supreme Court, 2004)
North American Mortgage Co. v. O'Hara
153 S.W.3d 43 (Texas Supreme Court, 2004)
Mills v. Warner Lambert Co.
157 S.W.3d 424 (Texas Supreme Court, 2005)
Henry Schein, Inc. v. Stromboe
102 S.W.3d 675 (Texas Supreme Court, 2002)
Southwestern Refining Co., Inc. v. Bernal
22 S.W.3d 425 (Texas Supreme Court, 2000)
Intratex Gas Co. v. Beeson
22 S.W.3d 398 (Texas Supreme Court, 2000)
Compaq Computer Corp. v. Albanese
153 S.W.3d 254 (Court of Appeals of Texas, 2004)
Warner-Lambert Co. v. Mills
117 S.W.3d 488 (Court of Appeals of Texas, 2003)
Central Power & Light Co. v. City of San Juan
962 S.W.2d 602 (Court of Appeals of Texas, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Warner-Lambert Company, Pfizer, Inc., Bayer Corporation, Del Pharmaceuticals, Inc., Del Laboratories, Inc. and Care Technologies, Inc. v. Katherine Mills and Veronica Evans, Individually and on Behalf of All Others Similarly Situated, Counsel Stack Legal Research, https://law.counselstack.com/opinion/warner-lambert-company-pfizer-inc-bayer-corporation-del-texapp-2005.